ScRNA-seq and bulk RNA-seq reveal the characteristics of ferroptosis and establish a risk signature in cholangiocarcinoma

IF 5.3 2区医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL

Molecular Therapy Oncolytics Pub Date : 2022-09-26 DOI:10.1016/j.omto.2022.09.008

W. Yao, Xuxu Liu, Yuanhang He, Maolan Tian, Shixin Lu, Qiang Wang, Yifeng Zheng, Zhenyi Lv, Chenjun Hao, Dongbo Xue, Xianzhi Meng

引用次数: 1

查看原文本刊更多论文

ScRNA-seq和bulk RNA-seq揭示了胆管癌铁下垂的特征，并建立了胆管癌的风险特征

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Molecular Therapy Oncolytics Medicine-Oncology

CiteScore

10.90

自引率

3.50%

发文量

152

审稿时长

6 weeks

期刊介绍： Molecular Therapy — Oncolytics is an international, online-only, open access journal focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer.